Meet Velico at upcoming conferences across North America and Europe and learn more about our FrontlineODP™ Spray Dried Plasma Manufacturing System. America’s Blood Centers (ABC) Annual Meeting, Tucson, Arizona (Mar 9–12) | DMHD – Defense Medical & Health Delivery Conference, London, UK (Mar 24–25)
Velico is a private, pre-clinical medical technology company headquartered in Beverly, MA. committed to the mission of stopping preventable death by bleeding. We are developing a breakthrough, On Demand Plasma platform technology, which will produce spray dried human plasma that will re-hydrate in minutes at the point of injury ready for rapid transfusion.

The FrontlineODP™ (On Demand Plasma) Manufacturing System turns liquid plasma into a spray dried powder in just over 30 minutes. The spray dried powdered plasma is easy to store, transport, and rehydrates when needed with just 200ml of sterile water.
The strength of FrontlineODP™ manufacturing system is its decentralized design and ability to scale quickly when needed.
Our system fits into existing blood centers, no clean room required
It uses trusted blood bank expertise and supply systems
Our system fits into existing blood centers, no clean room required
It uses trusted blood bank expertise and supply systems
Velcio recently completed a multicenter dose-escalation clinical trial which demonstrated that our FrontlineODP™ (On Demand Plasma) is both safe and retains potency comparable to PF24 starting material. No safety signals were identified by investigators, independent medical monitors, or the Data Monitoring Committee, and no thromboembolic events were observed.
In total, 66 spray dried plasma units were successfully manufactured and rehydrated with zero bag breakage, confirming reliable performance through the full process.
To meet demand, Velico is finalizing plans for new production facilities dedicated to manufacturing FrontlineODP™ consumables for the European and Indo-Pacific markets. Each fully automated, world-class facility will manufacture up to 250,000 units annually.
Combined with two U.S. facilities, Velico’s total manufacturing capacity would support production of nearly one million units of spray dried plasma per year.